We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Recommended process for contacting fathers-to-be to offer screening for sickle cell and thalassaemia.
Executive summary of quality assurance (QA) visit to Taunton and Somerset NHS Foundation Trust antenatal and newborn screening programmes on 17 September 2019.
Executive summary of quality assurance (QA) visit to East Lancashire Hospitals NHS Trust held on 9 and 10 November 2016.
Executive summary of quality assurance (QA) visit to Nottingham University Hospitals antenatal and newborn screening programmes on 7 and 8 October 2019.
Executive summary of the quality assurance (QA) visit to Dorset Hospital and Dorset HealthCare University NHS ANNB screening programmes on 22 January 2020.
Executive summary of quality assurance (QA) visit to the Princess Alexandra Hospital antenatal and newborn screening programmes on 15 and 16 October 2019.
Executive summary of quality assurance (QA) visit to Hampshire Hospitals NHS Foundation Trust's antenatal and newborn screening programme on 4 October 2016.
This document sets out the process for reporting newborn sickle cell disease screening results to parents.
Executive summary of quality assurance (QA) visit to Airedale NHS Foundation Trust antenatal and newborn screening programmes on 10 September 2019.
Remit for the Newborn Outcomes Information Governance and Clinical Board in sickle cell and thalassaemia screening.
Executive summary of the quality assurance visit to Calderdale and Huddersfield NHS Foundation Trust antenatal and newborn screening programmes on 5 February 2020.
Executive summary of quality assurance (QA) visit to North Tees and Hartlepool NHS Foundation Trust held on 27 June 2018.
Guidance to support NHS antenatal and newborn (ANNB) screening providers and commissioners in addressing inequalities throughout the screening pathway.
Executive summary of the quality assurance (QA) visit to Queen Elizabeth Hospital King's Lynn NHS antenatal and newborn screening programmes on 15 January 2020.
Executive summary of quality assurance visit to Great Western Hospitals NHS Foundation Trust's antenatal and newborn screening programme on 13 September 2016.
Template to record and submit newborn outcomes data for the sickle cell and thalassaemia (SCT) screening programme.
Executive summary of the quality assurance (QA) visit to Milton Keynes University Hospital NHS Foundation Trust ANNB screening programmes on 23 January 2020.
Executive summary of quality assurance (QA) visit to North West Anglia NHS Foundation Trust t held on 26 and 27 September 2018.
Executive summary of quality assurance (QA) visit to Epsom and St Helier University Hospitals held on 10, 29 and 30 November 2016.
Executive summary of the quality assurance (QA) visit to Barking, Havering and Redbridge University Hospitals NHS Trust on 12 and 13 February 2020.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).